Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).

Lorraine Martin; M. Pasteur; M. Keogan; Joseph Elborn; S. Buckingham; D. Bilton; J. Edgar

Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).

Lorraine Martin, M. Pasteur, M. Keogan, Joseph Elborn, S. Buckingham, D. Bilton, J. Edgar

Research output: Contribution to conference › Paper › peer-review

Original language	English
Pages	A191-A191
Number of pages	1
Publication status	Published - Mar 1999
Event	American Thoracic Society Conference - San Diego, CA, United States Duration: 07 Apr 1999 → 10 Apr 1999

Conference

Conference	American Thoracic Society Conference
Country/Territory	United States
City	San Diego, CA
Period	07/04/1999 → 10/04/1999

Bibliographical note

Published in the American Journal of Respiratory and Critical Care Medicine

Cite this

Martin, L., Pasteur, M., Keogan, M., Elborn, J., Buckingham, S., Bilton, D., & Edgar, J. (1999). Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).. A191-A191. Paper presented at American Thoracic Society Conference, San Diego, CA, United States.

@conference{e447123b8b944d05a30517e795eaa316,

title = "Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).",

author = "Lorraine Martin and M. Pasteur and M. Keogan and Joseph Elborn and S. Buckingham and D. Bilton and J. Edgar",

note = "Published in the American Journal of Respiratory and Critical Care Medicine; American Thoracic Society Conference ; Conference date: 07-04-1999 Through 10-04-1999",

year = "1999",

month = mar,

language = "English",

pages = "A191--A191",

}

Martin, L, Pasteur, M, Keogan, M, Elborn, J, Buckingham, S, Bilton, D & Edgar, J 1999, 'Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).', Paper presented at American Thoracic Society Conference, San Diego, CA, United States, 07/04/1999 - 10/04/1999 pp. A191-A191.

Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF). / Martin, Lorraine; Pasteur, M.; Keogan, M. et al.
1999. A191-A191 Paper presented at American Thoracic Society Conference, San Diego, CA, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).

AU - Martin, Lorraine

AU - Pasteur, M.

AU - Keogan, M.

AU - Elborn, Joseph

AU - Buckingham, S.

AU - Bilton, D.

AU - Edgar, J.

N1 - Published in the American Journal of Respiratory and Critical Care Medicine

PY - 1999/3

Y1 - 1999/3

M3 - Paper

SP - A191-A191

T2 - American Thoracic Society Conference

Y2 - 7 April 1999 through 10 April 1999

ER -